Call Options

8 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q4 2021

Feb 15, 2022

SELL
$8.12 - $10.37 $561,904 - $717,604
-69,200 Reduced 35.78%
124,200 $1.11 Million
Q3 2021

Nov 16, 2021

BUY
$7.48 - $11.38 $685,916 - $1.04 Million
91,700 Added 90.17%
193,400 $1.88 Million
Q2 2021

Aug 16, 2021

BUY
$7.16 - $9.56 $199,764 - $266,724
27,900 Added 37.8%
101,700 $839,000
Q1 2021

May 18, 2021

SELL
$8.52 - $19.21 $558,912 - $1.26 Million
-65,600 Reduced 47.06%
73,800 $704,000
Q4 2020

Feb 17, 2021

SELL
$9.3 - $15.19 $1.06 Million - $1.73 Million
-113,700 Reduced 44.92%
139,400 $1.3 Million
Q3 2020

Nov 17, 2020

SELL
$8.24 - $30.8 $1.02 Million - $3.8 Million
-123,300 Reduced 32.76%
253,100 $3.44 Million
Q2 2020

Aug 17, 2020

BUY
$7.46 - $23.42 $511,010 - $1.6 Million
68,500 Added 22.25%
376,400 $7.28 Million
Q1 2020

May 15, 2020

BUY
$0.91 - $17.81 $280,189 - $5.48 Million
307,900 New
307,900 $2.35 Million

Others Institutions Holding CODX

About Co-Diagnostics, Inc.


  • Ticker CODX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 33,781,000
  • Market Cap $43.2M
  • Description
  • Co-Diagnostics, Inc., a molecular diagnostics company, develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. It offers polymerase chain reaction (PCR) diagnostic tests for COVID-19, tuberculosis, hepatitis B and ...
More about CODX
Track This Portfolio

Track Jane Street Group, LLC Portfolio

Follow Jane Street Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.